Comments on DEA’s proposed rule on manufacturing and procurement quotas Pharmaceutical & Drug Policy Comments on DEA’s proposed rule on manufacturing and procurement quotas Marta E. WosiÅ„ska, Ben Graham July 29, 2026
By regulatory design: Geopolitical concentration in the US morphine supply chain Pharmaceutical & Drug Policy By regulatory design: Geopolitical concentration in the US morphine supply chain Marta E. Wosińska, Ben Graham July 27, 2026
Clarifying debates about drug decriminalization Pharmaceutical & Drug Policy Clarifying debates about drug decriminalization Beau Kilmer June 24, 2026
Comments on biosimilar streamlining efforts and context on commercial barriers to competition Pharmaceutical & Drug Policy Comments on biosimilar streamlining efforts and context on commercial barriers to competition Ryan Conrad May 7, 2026